21.53MMarket Cap
LossP/E TTM
Key Figures
2.030Open
2.120High
9.70KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.09%Turnover Ratio
2.040Prev. Close
2.000Low
5.84KTurnover
LossP/E Static
-4.33P/B
0.00%Div Yield TTM
-125.13%ROA
7.92052wk High
0.47Volume Ratio
-11.14MNet Profit
10.77MShares
-1.9647EPS TTM
1.20Beta
-296.12%ROE
1.22052wk Low
5.88%Amplitude
100.00%Gross Margin
21.53MMarket Cap
1.29Reward/Risk
5.69%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Serina Therapeutics Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 169 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 9.50.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Serina Therapeutics Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Serina Therapeutics Inc Highlights
StrengthsRisks
Serina Therapeutics Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Serina Therapeutics Inc
SER
2
Ionis Pharmaceuticals Inc
IONS
25
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Serina Therapeutics Inc Info
Serina Therapeutics Inc. is a clinical-stage biotechnology company developing a pipeline of wholly owned drug product candidates to treat neurological diseases and other indications. The Company's POZ Platform provides the potential to improve the integrated efficacy and safety profile of multiple modalities including small molecules, RNA-based therapeutics and antibody-based drug conjugates (ADCs). Its proprietary POZ technology is based on a synthetic, water soluble, low viscosity polymer called poly(2-oxazoline). Its POZ technology is engineered to provide greater control in drug loading and more precision in the rate of release of attached drugs delivered via subcutaneous injection. SER-252 is the Company’s lead candidate for advanced Parkinson’s disease. SER-252 is an investigational apomorphine therapy developed with its POZ platform and designed to provide continuous dopaminergic stimulation.
Ticker SymbolSER
CompanySerina Therapeutics Inc
CEOLedger (Steven)
Websitehttps://serinatherapeutics.com/
Shareholders
FAQs
What is the current price of Serina Therapeutics Inc (SER)?
The current price of Serina Therapeutics Inc (SER) is 2.01.
What is the symbol of Serina Therapeutics Inc?
The ticker symbol of Serina Therapeutics Inc is SER.
What is the 52-week high of Serina Therapeutics Inc?
The 52-week high of Serina Therapeutics Inc is 7.92.
What is the 52-week low of Serina Therapeutics Inc?
The 52-week low of Serina Therapeutics Inc is 1.22.
What is the market capitalization of Serina Therapeutics Inc?
The market capitalization of Serina Therapeutics Inc is 21.64M.
Is Serina Therapeutics Inc (SER) currently rated as Buy, Hold, or Sell?
According to analysts, Serina Therapeutics Inc (SER) has an overall rating of STRONG BUY, with a price target of 9.50.
What is the Earnings Per Share (EPS TTM) of Serina Therapeutics Inc (SER)?
The Earnings Per Share (EPS TTM) of Serina Therapeutics Inc (SER) is -1.88.
